<html dir="ltr"><head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<style>BODY {
        BACKGROUND-COLOR: #ffffff; FONT-FAMILY: arial,sans-serif; COLOR: black; FONT-SIZE: 10pt
}
P {
        MARGIN: 0px
}
</style>
<meta name="GENERATOR" content="MSHTML 8.00.6001.19019">
</head>
<body ocsi="x">
<div style="FONT-FAMILY: Tahoma; DIRECTION: ltr; COLOR: #000000; FONT-SIZE: 13px">
<div>As per Laurie Tenace's previous requests, I changed the subject heading since we sort of moved on to the DEA event and questions about the Secure and Responsible Drug Disposal Act.</div>
<div> </div>
<div>Hi Matt,</div>
<div><font size="2" face="tahoma">I know all about that. We have a fact sheet. :) I put an exerpt at the bottom of the message. There is always a percentage of people who will try to take advantage of "free" disposal.
</font><font size="2" face="tahoma">What I also know is that DEA here wants to include LTC waste as part of their April 30 event. I have asked that they keep that waste stream separate from the HH pharms, but I really don't know how this will turn out at this
point in time. </font></div>
<div><font size="2" face="tahoma"></font> </div>
<div>For MN, we have worked out a review and approval process for WTE's to accept HH only pharms for destruction. The CS have to be delivered by law enforcement for witnessed burn. However, EPA's and our state rules don't allow the LTC pharms to also go to
a SW WTE facility, so it greatly complicates disposal for DEA. It would be simpler if LTC's were left out, but the inclusion of LTC facilities is what has been proposed for MN at this point in time.
</div>
<div><font size="2" face="tahoma"></font><font size="2" face="tahoma"></font> </div>
<div><font size="2" face="tahoma">I am curious if other states have had their DEA talk with them about including LTC facilities in the April event. There may be some reason or pressure to include them because they are called out in the Secure and Responsible
Drug Disposal Act. This would also be another reason to segregate that waste stream for this event--in order to generate some data. </font></div>
<div><font size="2" face="tahoma"></font> </div>
<div><font size="2" face="tahoma">
<table dir="ltr" border="1" cellspacing="0" borderColor="#000000" cellpadding="7" width="550">
<tbody>
<tr>
<td height="289" valign="top">
<p align="left"></p>
<p><font size="3"><font size="2" face="Calibri">Pharmaceutical hazardous waste generated from commercial activities is regulated hazardous waste in Minnesota regardless of where it is generated. Pharmaceutical waste generated from non-commercial household activities
is unregulated household hazardous waste in Minnesota, unless and until collected by a household hazardous waste collection program. Health care providers that generate pharmaceutical hazardous wastes from commercial activities are regulated hazardous waste
generators. The MPCA considers that the degree of centralized control and storage of pharmaceuticals in a facility is the most significant indicator of generation from commercial activities. Applying this indicator:
</font></p>
<ol>
<li><font size="2" face="Calibri">Pharmaceuticals stored in a centralized, employee-controlled location separate from resident living areas, such as is required at hospitals, nursing homes, and boarding-care homes, will be considered generated from commercial
activities and therefore regulated when discarded. </font></li><li></font><font size="2" face="Calibri">Pharmaceuticals stored in resident rooms or other non-central and unrestricted-access location, such as at home-care client houses, may be considered generated from non-commercial household activities and therefore unregulated
when discarded. </font></li></ol>
</td>
</tr>
</tbody>
</table>
</font></div>
<div dir="ltr"><font color="#000000" size="2" face="Tahoma"></font> </div>
<div style="DIRECTION: ltr" id="divRpF616768">
<hr tabindex="-1">
<font color="#000000" size="2" face="Tahoma"><b>From:</b> Matthew C. Mireles [mirelesmc@earthlink.net]<br>
<b>Sent:</b> Wednesday, March 16, 2011 4:06 PM<br>
<b>To:</b> Volkman, Jennifer (MPCA); pharmwaste@lists.dep.state.fl.us<br>
<b>Subject:</b> RE: [Pharmwaste] Rite Aid now partnered with Sharp'sComplianceCorporation to sell drug mail back envelopes<br>
</font><br>
</div>
<div></div>
<div>
<p><font color="#000000"><font size="2"><font face="arial,sans-serif">Jennifer,</font></font></font></p>
<p><font color="#000000"><font size="2"><font face="arial,sans-serif">You may have to check with your state's regulations regarding definition, oversight and requirements for LTC facilities. In TX, they are considered healthcare institutions and must comply
with the reverse distribution system for drug disposal. Most of the programs that are discussed on this listserv including the DEA's national campaign (Sept 25 and April 30 collection dates) are specifically designed for consumer drug return. We were exploring
a research project involving mortality review of patient cases from LTC, often renamed as "state schools", as part of a patient safety initiative for the TX DHHS. Nursing homes and some assisted home facilities fall under LTC facilities but rules vary from
state to state. We discourage hospitals and organized clinics and medical offices from using community-based drug take-back system. I believe in Houston one DEA officer turned away a doctor who was emptying his stockroom. My guess is that compliance to
any program would be difficult and impossible to enforce. <br>
</p>
</font></font></font>
<blockquote style="BORDER-LEFT: #0000ff 2px solid; PADDING-LEFT: 5px; MARGIN-LEFT: 0px">
-----Original Message----- <br>
From: "Volkman, Jennifer (MPCA)" <br>
Sent: Mar 16, 2011 2:02 PM <br>
To: "pharmwaste@lists.dep.state.fl.us" <br>
Subject: RE: [Pharmwaste] Rite Aid now partnered with Sharp'sComplianceCorporation to sell drug mail back envelopes
<br>
<br>
<style>
<!--
@font-face
        {font-family:Calibri}
@font-face
        {font-family:Tahoma}
@font-face
        {font-family:Verdana}
@page Section1
        {margin:1.0in 1.0in 1.0in 1.0in}
p.MsoNormal
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:12pt}
li.MsoNormal
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:12pt}
div.MsoNormal
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:12pt}
a:link
        {color:blue;
        text-decoration:underline}
span.MsoHyperlink
        {color:blue;
        text-decoration:underline}
a:visited
        {color:purple;
        text-decoration:underline}
span.MsoHyperlinkFollowed
        {color:purple;
        text-decoration:underline}
p
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:12pt}
p.msochpdefault
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:10pt}
li.msochpdefault
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:10pt}
div.msochpdefault
        {margin:0in 0in 0pt;
        font-family:"Times New Roman","serif";
        font-size:10pt}
span.emailstyle18
        {font-family:"Calibri","sans-serif";
        color:#1f497d}
span.emailstyle19
        {font-family:"Calibri","sans-serif";
        color:#1f497d}
span.emailstyle20
        {font-style:normal;
        font-family:"Times New Roman","serif";
        color:navy;
        font-weight:normal;
        text-decoration:none}
span.emailstyle22
        {font-family:"Calibri","sans-serif";
        color:#1f497d}
span.EmailStyle24
        {font-family:"Calibri","sans-serif";
        color:#1f497d}
.msochpdefault
        {font-size:10pt}
-->
</style><style id="owaTempEditStyle"></style><style title="owaParaStyle"><!--P {
        MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px
}
--></style>
<div style="FONT-FAMILY: Tahoma; DIRECTION: ltr; COLOR: #000000; FONT-SIZE: 13px">
<div>Charlotte, I hope you are in on that rule drafting business. I suppose there isn't much of an update from the first hearing, but anything you can share would be appreciated. I am hoping that EPA is involved and considering what can be done to help out
the LTC facilities. DEA in MN wants to include them in the April 30 collection event, which is more problematic from a disposal perspective than just managing household waste.
</div>
<div><font size="2" face="tahoma"></font> </div>
<div><font size="2" face="tahoma">It is also difficult to explain EPA's distinction that pharms confiscated during a drug bust are considered to be business waste while the same pharms turned in by a household at a collection event or drop box are household
waste and are not regulated by EPA. </font></div>
<div> </div>
<div>With all due respect to DEA for their efforts, I would rather see them focused on the criminal element and to leave collection and disposal to those experts.
</div>
<div><font color="#000000" size="2" face="Tahoma"></font> </div>
<div style="DIRECTION: ltr" id="divRpF559687">
<hr tabindex="-1">
<font color="#000000" size="2" face="Tahoma"><b>From:</b> pharmwaste-bounces@lists.dep.state.fl.us [pharmwaste-bounces@lists.dep.state.fl.us] On Behalf Of Smith, Charlotte [csmith@pharmecology.com]<br>
<b>Sent:</b> Wednesday, March 16, 2011 1:15 PM<br>
<b>To:</b> Volkman, Jennifer (MPCA); Jan Harris; DeBiasi, Deborah (DEQ); pharmwaste@lists.dep.state.fl.us<br>
<b>Subject:</b> RE: [Pharmwaste] Rite Aid now partnered with Sharp'sComplianceCorporation to sell drug mail back envelopes<br>
</font><br>
</div>
<div></div>
<div>
<div class="Section1">
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Please note that no DEA-registered reverse distributors are currently authorized to accept controlled substances from consumers, only from other DEA registrants.
The DEA is currently drafting regulations that will enable some type of consumer take-back process, but these have not been published or finalized as of yet.
</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt"></span> </p>
<div>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Best regards,</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt"></span> </p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Charlotte A. Smith, R. Ph., M.S., HEM</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Director, PharmEcology Services</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">WM Healthcare Solutions, Inc.
</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">W124N8925 Boundary Road</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">Menomonee Falls, WI 53051-2402</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">713-725-6363 (cell)</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">414-292-3959</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">414-479-9941(fax)</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt">csmith@pharmecology.com</span></p>
<p class="MsoNormal"><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt"></span> </p>
<p class="MsoNormal"><b><i><span style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #00b050; FONT-SIZE: 11pt">Waste Management's renewable energy projects create enough energy to power over 1 million homes.</span></i></b></p>
</div>
</div>
</div>
</div>
</blockquote>
</div>
</div>
</body>
</html>